Literature DB >> 17913520

Five day antibiotic prophylaxis for major lower limb amputation reduces wound infection rates and the length of in-hospital stay.

U Sadat1, A Chaudhuri, P D Hayes, M E Gaunt, J R Boyle, K Varty.   

Abstract

OBJECTIVE: To compare wound infection, revision rates and hospital stay after major lower limb amputation between patients receiving 24 hours versus 5 days of prophylactic antibiotics.
METHODS: The outcomes of a consecutive series of 40 major lower limb amputations in patients receiving a short 24-hour course of combined prophylactic antibiotics (flucloxacillin/vancomycin + gentamicin/ciproxin + metronidazole) were retrospectively analysed. Following this a further consecutive group of 40 major lower limb amputations were studied prospectively following the institution of a 5-day combined regime using the same antibiotics.
RESULTS: The 2 groups of patients were similar in terms of demographics, vascular risk factors and level of amputation. The 5-day antibiotic regime led to a significant reduction in wound infection rates (5% vs. 22.5%, P=0.023) and a reduced length of hospital stay (22 vs. 34 days, P=0.001). Revision rates were lower (2.5% vs. 10%) but did not reach statistical significance (P=0.36). More patients in the prospective 5-day antibiotic series were operated on by the vascular trainee. (77.5% vs. 55% P=0.033).
CONCLUSIONS: This data supports the use of a prolonged 5-day course of combined antibiotics after major lower limb amputation. This appears to reduce stump infection rates leading to shorter in-hospital stay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913520     DOI: 10.1016/j.ejvs.2007.07.016

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  8 in total

1.  Hospital infection after major amputations.

Authors:  José Maria Pereira de Godoy; Janalice Vasconcelos Ribeiro; Lívia Andrioli Caracanhas; Maria de Fátima Guerreiro Godoy
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-05-19       Impact factor: 3.944

2.  An analysis of risk factors associated with traumatic extremity amputation stump wound infection in a Nigerian setting.

Authors:  Njoku Isaac Omoke; Chinedu Gregory Nwigwe
Journal:  Int Orthop       Date:  2012-09-01       Impact factor: 3.075

3.  Impact of high prevalence of pseudomonas and polymicrobial gram-negative infections in major sub-/total traumatic amputations on empiric antimicrobial therapy: a retrospective study.

Authors:  Moritz T Giesecke; Philipp Schwabe; Florian Wichlas; Andrej Trampuz; Christian Kleber
Journal:  World J Emerg Surg       Date:  2014-10-25       Impact factor: 5.469

4.  Stopping antibiotics after surgical amputation in diabetic foot and ankle infections-A daily practice cohort.

Authors:  Anne Rossel; Dan Lebowitz; Karim Gariani; Mohamed Abbas; Benjamin Kressmann; Mathieu Assal; Philippe Tscholl; Dimitrios Stafylakis; Ilker Uçkay
Journal:  Endocrinol Diabetes Metab       Date:  2019-02-06

5.  Comparison of three antimicrobial strategies in diabetic foot infections post-amputation.

Authors:  Samarth P Shah; Ana Negrete; Timothy Self; Jaclyn Bergeron; Jennifer D Twilla
Journal:  Ther Adv Infect Dis       Date:  2019-07-17

6.  A pilot feasibility randomised clinical trial comparing dialkylcarbamoylchloride-coated dressings versus standard care for the primary prevention of surgical site infection.

Authors:  Joshua P Totty; Louise H Hitchman; Paris L Cai; Amy E Harwood; Tom Wallace; Dan Carradice; George E Smith; Ian C Chetter
Journal:  Int Wound J       Date:  2019-03-14       Impact factor: 3.315

7.  Compartment Syndrome following Below-Knee Amputation.

Authors:  Adam S Gerry; Zachary K Christopher; Karan Patel; Todd A Kile; Joshua S Bingham
Journal:  Case Rep Orthop       Date:  2022-02-21

8.  Surgical Antimicrobial Prophylaxis in Patients of Neonatal and Pediatric Age Undergoing Orthopedic and Hand Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Francesca Opri; Sonia Bianchini; Laura Nicoletti; Sara Monaco; Roberta Opri; Marilia Di Pietro; Elena Carrara; Erika Rigotti; Cinzia Auriti; Caterina Caminiti; Daniele Donà; Laura Lancella; Andrea Lo Vecchio; Simone Pizzi; Nicola Principi; Alessandro Simonini; Simonetta Tesoro; Eisabetta Venturini; Alberto Villani; Annamaria Staiano; Leonardo Marchesini Reggiani; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.